Cytochrome P450-derived renal HETEs: storage and release - PubMed (original) (raw)
. 1997 Jun;51(6):1696-702.
doi: 10.1038/ki.1997.234.
Affiliations
- PMID: 9186856
- DOI: 10.1038/ki.1997.234
Free article
Cytochrome P450-derived renal HETEs: storage and release
M A Carroll et al. Kidney Int. 1997 Jun.
Free article
Abstract
We have established an assay based on gas chromatography-mass spectrometry to profile and quantitate endogenous cytochrome P450 monooxygenase (P450)-hydroxyeicosatetraenoic acids (HETEs) exiting the isolated perfused rabbit kidney in response to hormonal stimulation. In response to angiotensin II (Ang II) P450-derived HETEs (16-, 17-, 18-, 19- and 20-) are released from the isolated Kreb's perfused rabbit kidney. Ang II produced a several-fold increase in the levels of P450-HETEs above basal levels in both urinary (such as for 20-HETE from 0.93 +/- 0.7 to 2.31 +/- 0.9 ng/min) and venous (from 0.1 +/- 0.05 to 0.3 +/- 0.05 ng/min) effluents. However, inhibition of P450, which reduced basal release, did not prevent Ang II-induced release of P450-AA products from the rabbit kidney; for example, urinary 20-HETE in the presence of 17-ODYA (1 microM) was undetectable and increased to 0.93 +/- 0.4 ng/min with Ang II and venous 20-HETE increased from 0.06 +/- 0.03 to 0.24 +/- 0.07 ng/min. Similar results were obtained with clotrimazole (1 microM). As 16-, 18-, 19- and 20-HETEs are vasodilators in the rabbit kidney and 16- and 17-HETEs inhibit proximal tubular ATPase activity, we investigated their possible sites of esterification. Cortical and medullary lipids were extracted, separated by HPLC and P450-HETEs quantitated following alkaline hydrolysis. The P450-HETEs were incorporated into both neutral lipids (NL) and phospholipids [phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS) and phosphatidylcholine (PC)]. However, the assignment of a HETE to a specific phospholipid pool must be regarded as tentative as the appropriate standards containing P450-HETEs in the Sn-2 position (such as 20-HETE-PF., 20-HETE-PC, etc.) were not available. Esterified HETEs were found in larger quantities in the cortex as compared to the medulla (34.40 +/- 1.12 versus 22.76 +/- 0.53 ng/g). The PI fraction in the cortex yielded the largest quantity of HETEs and the PC fraction the lowest. In the medulla, the largest quantities of esterified HETEs were found in neutral lipids and only slightly lesser amounts in PE and PI. Esterified 18-HETE was localized only to the NI fraction. This fraction also contained the other HETEs, 19- and 20-HETE being the most abundant. Notably only 16- and 17-HETE were present in PF, whereas, 19- and 20-HETE were also present in PI, PS and PC. Thus, P450-HETEs, like EETs are stored in the kidney and are, presumably, subject to release by peptide activation of acylhydrolases.
Similar articles
- Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides.
Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, McGiff JC. Carroll MA, et al. Am J Physiol. 1996 Oct;271(4 Pt 2):R863-9. doi: 10.1152/ajpregu.1996.271.4.R863. Am J Physiol. 1996. PMID: 8897975 - Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D, Gatta A, McGiff JC. Sacerdoti D, et al. Prostaglandins Other Lipid Mediat. 2003 Oct;72(1-2):51-71. doi: 10.1016/s1098-8823(03)00077-7. Prostaglandins Other Lipid Mediat. 2003. PMID: 14626496 Review. - Effects of hydroxyeicosatetraenoic acids on fatty acid esterification in phospholipids and insulin secretion in pancreatic islets.
Laychock SG. Laychock SG. Endocrinology. 1985 Sep;117(3):1011-9. doi: 10.1210/endo-117-3-1011. Endocrinology. 1985. PMID: 3926463 - Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1.
Laethem RM, Balazy M, Falck JR, Laethem CL, Koop DR. Laethem RM, et al. J Biol Chem. 1993 Jun 15;268(17):12912-8. J Biol Chem. 1993. PMID: 8509425 - Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states.
Shoieb SM, El-Sherbeni AA, El-Kadi AOS. Shoieb SM, et al. Chem Biol Interact. 2019 Feb 1;299:140-150. doi: 10.1016/j.cbi.2018.12.004. Epub 2018 Dec 10. Chem Biol Interact. 2019. PMID: 30543782 Review.
Cited by
- 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.
Williams JM, Murphy S, Burke M, Roman RJ. Williams JM, et al. J Cardiovasc Pharmacol. 2010 Oct;56(4):336-44. doi: 10.1097/FJC.0b013e3181f04b1c. J Cardiovasc Pharmacol. 2010. PMID: 20930591 Free PMC article. Review. - Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.
Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH. Arnold C, et al. J Biol Chem. 2010 Oct 22;285(43):32720-32733. doi: 10.1074/jbc.M110.118406. Epub 2010 Aug 23. J Biol Chem. 2010. PMID: 20732876 Free PMC article. - Vascular actions of 20-HETE.
Hoopes SL, Garcia V, Edin ML, Schwartzman ML, Zeldin DC. Hoopes SL, et al. Prostaglandins Other Lipid Mediat. 2015 Jul;120:9-16. doi: 10.1016/j.prostaglandins.2015.03.002. Epub 2015 Mar 23. Prostaglandins Other Lipid Mediat. 2015. PMID: 25813407 Free PMC article. Review. - 20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes.
Roshanravan H, Kim EY, Dryer SE. Roshanravan H, et al. Front Physiol. 2016 Aug 31;7:351. doi: 10.3389/fphys.2016.00351. eCollection 2016. Front Physiol. 2016. PMID: 27630573 Free PMC article. - Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor.
Tunaru S, Chennupati R, Nüsing RM, Offermanns S. Tunaru S, et al. PLoS One. 2016 Sep 23;11(9):e0163633. doi: 10.1371/journal.pone.0163633. eCollection 2016. PLoS One. 2016. PMID: 27662627 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous